| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Receptos Inc | 478,800 | 20,397,000 | 5.40% | ||
| 2 | OMEROS CORP | 1,123,000 | 19,540,000 | 5.18% | ||
| 3 | Questcor | 200,000 | 18,498,000 | 4.90% | ||
| 4 | KARYOPHARM THERAPEUTICS INC | 385,000 | 17,922,000 | 4.75% | ||
| 5 | DYAX CORP COM CVR | 1,800,000 | 17,280,000 | 4.58% | ||
| 6 | CELGENE CORP | 200,000 | 17,176,000 | 4.55% | ||
| 7 | BIOCRYST PHARMACEUTICALS | 1,168,000 | 14,892,000 | 3.95% | ||
| 8 | JAZZ PHARMACEUTICALS PLC | 100,000 | 14,701,000 | 3.90% | ||
| 9 | PUMA BIOTECHNOLOGY INC | 207,500 | 13,695,000 | 3.63% | ||
| 10 | Arrowhead Pharma Inc | 900,000 | 12,879,000 | 3.41% | ||
| 11 | Akebia Therapeutics, Inc. | 400,000 | 11,116,000 | 2.95% | ||
| 12 | GALECTIN THERAPEUTICS INC | 800,000 | 11,048,000 | 2.93% | ||
| 13 | TESARO INC | 300,000 | 9,333,000 | 2.47% | ||
| 14 | HERON THERAPEUTICS INC | 700,000 | 8,624,000 | 2.29% | ||
| 15 | DEXCOM INC | 200,000 | 7,932,000 | 2.10% | ||
| 16 | SANGAMO THERAPEUTICS INC | 500,000 | 7,635,000 | 2.02% | ||
| 17 | MALLINCKRODT PLC | 90,000 | 7,202,000 | 1.91% | ||
| 18 | ACELRX PHARMACEUTICALS INC | 700,000 | 7,175,000 | 1.90% | ||
| 19 | NOVAVAX INC | 1,500,000 | 6,930,000 | 1.84% | ||
| 20 | ACCELERON PHARMA INC | 200,000 | 6,794,000 | 1.80% | ||
| 21 | SORRENTO THERAPEUTICS INC | 1,000,000 | 6,750,000 | 1.79% | ||
| 22 | CHIMERIX INC | 300,000 | 6,582,000 | 1.74% | ||
| 23 | PORTOLA PHARMACEUTICALS INC | 200,000 | 5,836,000 | 1.55% | ||
| 24 | MERCK AND CO INC | 100,000 | 5,785,000 | 1.53% | ||
| 25 | EAGLE PHARMACEUTICALS INC | 400,000 | 5,732,000 | 1.52% | ||
| 26 | Versartis, Inc. | 200,000 | 5,608,000 | 1.49% | ||
| 27 | ULTRAGENYX PHARMACEUTICAL INC | 120,000 | 5,387,000 | 1.43% | ||
| 28 | APPLIED GENETIC TECHNOL CORP | 218,600 | 5,050,000 | 1.34% | ||
| 29 | ALKERMES PLC | 100,000 | 5,033,000 | 1.33% | ||
| 30 | ROCKWELL MED INC | 400,000 | 4,796,000 | 1.27% | ||
| 31 | Array BioPharma Inc. | 1,000,000 | 4,560,000 | 1.21% | ||
| 32 | PUMA BIOTECHNOLOGY INC | 5,000 | 4,500,000 | 1.19% | ||
| 33 | NANOSTRING TECHNOLOGIES INC | 300,000 | 4,485,000 | 1.19% | ||
| 34 | NEUROCRINE BIOSCIENCES INC | 300,000 | 4,451,000 | 1.18% | ||
| 35 | CHINA BIOLOGIC PRODUCTS INC | 100,000 | 4,447,000 | 1.18% | ||
| 36 | QUOTIENT LTD | 500,000 | 4,180,000 | 1.11% | ||
| 37 | RECRO PHARMA INC | 500,000 | 4,005,000 | 1.06% | ||
| 38 | GLYCOMIMETICS INC | 472,300 | 3,981,000 | 1.05% | ||
| 39 | PTC THERAPEUTICS INC | 150,000 | 3,921,000 | 1.04% | ||
| 40 | GENVEC INC | 1,329,300 | 3,416,000 | 0.91% | ||
| 41 | ALNYLAM PHARMACEUTICALS INC | 50,000 | 3,159,000 | 0.84% | ||
| 42 | ALDER BIOPHARMACEUTICALS INC | 150,000 | 3,011,000 | 0.80% | ||
| 43 | Clovis Oncology, Inc. | 70,000 | 2,899,000 | 0.77% | ||
| 44 | AGENUS INC | 900,000 | 2,898,000 | 0.77% | ||
| 45 | AQUINOX PHARMACEUTICALS INC | 300,000 | 2,829,000 | 0.75% | ||
| 46 | CERULEAN PHARMA INC | 450,000 | 2,610,000 | 0.69% | ||
| 47 | AUSPEX PHARMACEUTICALS INC | 100,000 | 2,227,000 | 0.59% | ||
| 48 | KINDRED BIOSCIENCES INC | 100,000 | 1,864,000 | 0.49% | ||
| 49 | REGULUS THERAPEUTICS INC | 200,000 | 1,608,000 | 0.43% | ||
| 50 | AGILE THERAPEUTICS INC | 150,000 | 1,308,000 | 0.35% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-14-032474, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
